Ibrance Side Effects

Ibrance is a targeted therapy known as a cdk 4 6 inhibitor.

Ibrance side effects.

Ibrance may cause serious side effects including. Low white blood cell counts neutropenia. Your doctor should check your white blood cell counts before and during treatment. If experienced these tend to have a severe expression.

Learn about dosage side effects and more. Less commonly ibrance may cause serious side effects including. Taken in combination with certain hormonal therapies ibrance works to put the brakes on cell growth in both healthy and cancer cells. You may report side effects to fda at 1 800 fda 1088.

Our ibrance palbociclib side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication. Severe neutropenia very low white blood cell count. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Nausea vomiting loss of appetite diarrhea tiredness weakness hair loss mouth sores or numbness tingling of arms legs may occur. Low white blood cell counts are very common when taking ibrance and may cause serious infections that can lead to death. In postmenopausal women ibrance is given in combination with a hormonal medicine such as letrozole in others ibrance is given together with. This helps slow the progression of cancer but it can also cause side effects some of which are serious.

Decreased neutrophils other side effects include. A high alanine transaminase level. Infection and pulmonary embolism. Low white blood cell counts are a common side effect of ibrance.

If any of these effects persist or worsen. Ibrance palbociclib is a cancer medicine that interferes with the growth and spread of cancer cells in the body ibrance is used in men and women to treat hr positive her2 negative breast cancer that has spread to other parts of the body. Common side effects of ibrance include. It is not a traditional chemotherapy.

Still some people s white blood cell counts may drop so low that they have to decrease the dose or of ibrance or stop treatment. See below for a comprehensive list of adverse effects. Ibrance is the first fda approved medication in its class. It treats breast cancer that s metastatic hr positive and her2 negative.

This document contains side effect information about palbociclib.